Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Efavirenz in plasma from HIV-infected patients does not directly block reverse transcriptase activity in cell-free assays but inhibits HIV replication in cellular assays.

Burrer R, Spiridon G, Einius-Haessig S, Richert S, Salmon-Ceron D, Pancino G, Aubertin AM, Moog C.

AIDS Res Hum Retroviruses. 2006 Sep;22(9):865-9.

PMID:
16989611
2.

A cohort study of enfuvirtide immunological and virological efficacy in clinical practice.

Bienvenu B, Krivine A, Rollot F, Pietri MP, Lebault V, Meritet JF, Guerin C, Spiridon G, Salmon D, Guillevin L, Lebon P, Launay O.

J Med Virol. 2006 Oct;78(10):1312-7.

PMID:
16927284
3.

Feasibility of azithromycin prophylaxis during a pertussis outbreak among healthcare workers in a university hospital in Paris.

Giugliani C, Vidal-Trecan G, Traore S, Blanchard H, Spiridon G, Rollot F, Launay O, Gorodestski M, Marande JL, Vinsonneau C, Guillevin L, Salmon-Ceron D.

Infect Control Hosp Epidemiol. 2006 Jun;27(6):626-9. Epub 2006 May 31.

PMID:
16755485
4.

Nodular regenerative hyperplasia of the liver after IL-2 therapy in an HIV-infected patient.

Podevin P, Spiridon G, Terris B, Chauvelot-Moachon L, Guillevin L, Chaussade S, Sogni P, Salmon-Ceron D.

AIDS. 2006 Jan 9;20(2):313-5. No abstract available.

PMID:
16511439
5.

Bacterial prostatitis due to Pseudomonas aeruginosa harbouring the blaVIM-2 metallo-{beta}-lactamase gene from Saudi Arabia.

Guerin F, Henegar C, Spiridon G, Launay O, Salmon-Ceron D, Poyart C.

J Antimicrob Chemother. 2005 Sep;56(3):601-2. Epub 2005 Aug 8. No abstract available.

PMID:
16087655
6.

[Antiretroviral agents in HIV-infected patients with cirrhosis].

Salmon-Céron D, Sogni P, Spiridon G, Taburet AM.

Presse Med. 2005 Jun 4;34(10 Suppl):1S45-52. Review. French.

PMID:
16025667
7.

[Prevalence and risk factors of hepatitis A infection in an HIV-infected French population].

Brunet A, Grabar S, Blanche P, Héripret-Fredouille L, Spiridon G, Calboreanu A, Rollot F, Launay O, Sicard D, Salmon-Céron D, Abad S.

Med Mal Infect. 2005 Feb;35(2):73-81. French.

PMID:
15780896
8.

Once-daily dosing of saquinavir soft-gel capsules and ritonavir combination in HIV-1-infected patients (IMEA015 study).

Lamotte C, Landman R, Peytavin G, Mentre F, Gerbe J, Brun-Vezinet F, Boue F, Spiridon G, Valantin MA, Michelet C, Farinotti R, Yeni P.

Antivir Ther. 2004 Apr;9(2):247-56.

PMID:
15134187
9.

Immunoglobulin G (IgG) and IgA, but also nonantibody factors, account for in vitro neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by serum and plasma of HIV-infected patients.

Burrer R, Salmon-Ceron D, Richert S, Pancino G, Spiridon G, Haessig S, Roques V, Barre-Sinoussi F, Aubertin AM, Moog C.

J Virol. 2001 Jun;75(11):5421-4.

Supplemental Content

Loading ...
Support Center